Effect of Oxyethylene Moieties in Hydrogenated Castor Oil on the Pharmacokinetics of Menatetrenone Incorporated in O/W Lipid Emulsions Prepared with Hydrogenated Castor Oil and Soybean Oil in Rats

References

• Allen, T.M., Hansen, C., Martin, F., Redemann, C. and Yau-Young, A. (1991) “Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo”, Biochim. Biophys. Acta 1066, 29 -36.
   PubMed Web of Science ®Google Scholar
• Davis, S.S. (1997) “Biomedical applications of nanotechnology- implications for drug targeting and gene therapy”, Trends Biotechnol. 15, 217 -224.
   PubMed Web of Science ®Google Scholar
• Dunn, S.E., Brindley, A., Davis, S.S., Davies, M.C. and Illum, L. (1994) “Polystylene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution”, Pharm. Res. 11, 1016–1022.
   PubMed Web of Science ®Google Scholar
• Illum, L., Davis, S.S., Mu¨ller, R.H., Mak, E. and West, P. (1987) “The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer— poloxamine 908”, Life Sci. 40, 367 -374.
   PubMed Web of Science ®Google Scholar
• Klibanov, A.L., Maruyama, K., Torchilin, V.P. and Huang, L. (1990) “Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes”, FEBS Lett. 268, 235 -237.
   PubMed Web of Science ®Google Scholar
• Kurihara, A., Shibayama, Y., Yasuno, A., Ikeda, M. and Hisaoka, M. (1996) “Lipid emulsions of palmitoylrhizoxin: effects of particle size on blood dispositions of emulsion lipid and incorporated compound in rats”, Biopharm. Drug Dispos. 17, 343 -353.
   PubMed Web of Science ®Google Scholar
• Liu, F. and Liu, D. (1995) “Long-circulating emulsions (oil- in-water) as carriers for lipophilic drugs”, Pharm. Res. 12, 1060–1064.
   PubMed Web of Science ®Google Scholar
• Lundberg, B.B., Mortimer, B.-C. and Redgrave, T.G. (1996) “Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drug-carriers with prolonged circulation time”, Int. J. Pharm. 134, 119 -127.
   Web of Science ®Google Scholar
• Moghimi, S.M., Muir, I.S., Illum, L., Davis, S.S. and Kolb-Bachofen, V. (1993) “Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum”, Biochim. Biophys. Acta 1179, 157 -165.
   PubMed Web of Science ®Google Scholar
• Moghimi, S.M., Hunter, A.C. and Murray, J.C. (2001) “Long-circulating and target-specific nanoparticles: theory to practice”, Pharmacol. Rev. 53, 283 -318.
   PubMed Web of Science ®Google Scholar
• Mori, A., Klibanov, A.L., Torchilin, V.P. and Huang, L. (1991) “Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo”, FEBS Lett. 284, 263 -266.
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., Lee, K.-D., Woodle, M.C., Lasic, D.D., Redemann, C. and Martin, F.J. (1991) “Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy”, Proc. Natl Acad. Sci. USA 88, 11460–11464.
   PubMed Web of Science ®Google Scholar
• Sakaeda, T. and Hirano, K. (1995) “O/W lipid emulsions for parenteral drug delivery. II. Effect of composition on pharmacokinetics of incorporated drug”, J. Drug Target. 3, 221 -230.
   PubMed Web of Science ®Google Scholar
• Sakaeda, T. and Hirano, K. (1998a) “O/W lipid emulsions for parenteral drug delivery. III. Lipophilicity necessary for incorporation in oil particles even after intravenous injection”, J. Drug Target. 6, 119 -127.
   Web of Science ®Google Scholar
• Sakaeda, T. and Hirano, K. (1998b) “Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions”, J. Drug Target. 6, 273 -284.
   Web of Science ®Google Scholar
• Stolnik, S., Daudali, B., Arien, A., Whetstone, J., Heald, C.R., Garnett, M.C., Davis, S.S. and Illum, L. (2001) “The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers”, Biochim. Biophys. Acta 1514, 261 -279.
   PubMed Web of Science ®Google Scholar
• Takino, T., Konishi, K., Takakura, Y. and Hashida, M. (1994) “Long circulating emulsion carrier systems for highly lipophilic drugs”, Biol. Pharm. Bull. 17, 121 -125.
   PubMed Web of Science ®Google Scholar
• Ueda, K., Ishida, M., Inoue, T., Fujimoto, M., Kawahara, Y., Sakaeda, T. and Iwakawa, S. (2001) “Effect of injection volume on the pharmacokinetics of oil particles and incorporated menatetrenone after intravenous injection as O/W lipid emulsions in rats”, J. Drug Target. 9, 353 -360.
   PubMed Web of Science ®Google Scholar
• Ueda, K., Fujimoto, M., Noto, H., Kawaguchi, Y., Sakaeda, T. and Iwakawa, S. (2002) “Effect of oxyethylene moiety in polyoxyethyl- ene sorbitan esters on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with polyoxyethylene sorbitan esters and soybean oil in rats”, J. Pharm. Pharmacol. 54, 1357–1363.
   PubMed Web of Science ®Google Scholar
• Yuda, T., Maruyama, K. and Iwatsuru, M. (1996) “Prolongation of liposome circulation time by various derivatives of polyethylene- glycols”, Biol. Pharm. Bull. 19, 1347–1351.
   PubMed Web of Science ®Google Scholar